The 2003 SARS outbreak and its impact on infection control practices.
Identifieur interne : 002443 ( PubMed/Corpus ); précédent : 002442; suivant : 002444The 2003 SARS outbreak and its impact on infection control practices.
Auteurs : Karen ShawSource :
- Public health [ 0033-3506 ] ; 2006.
English descriptors
- KwdEn :
- MESH :
- epidemiology : Severe Acute Respiratory Syndrome, United Kingdom.
- methods : Infection Control.
- pathogenicity : Coronavirus.
- transmission : Severe Acute Respiratory Syndrome.
- Disease Outbreaks, Humans, Infectious Disease Transmission, Patient-to-Professional, State Medicine.
Abstract
Severe Acute Respiratory Syndrome (SARS) emerged recently as a new infectious disease that was transmitted efficiently in the healthcare setting and particularly affected healthcare workers (HCWs), patients and visitors. The efficiency of transmission within healthcare facilities was recognised following significant hospital outbreaks of SARS in Canada, China, Hong Kong, Singapore, Taiwan and Vietnam. The causative agent of SARS was identified as a novel coronavirus, the SARS coronavirus. This was largely spread by direct or indirect contact with large respiratory droplets, although airborne transmission has also been reported. High infection rates among HCWs led initially to the theory that SARS was highly contagious and the concept of 'super-spreading events'. Such events illustrated that lack of infection control (IC) measures or failure to comply with IC precautions could lead to large-scale hospital outbreaks. SARS was eventually contained by the stringent application of IC measures that limited exposure of HCWs to potentially infectious individuals. As the 'global village' becomes smaller and other microbial threats to health emerge, or re-emerge, there is an urgent need to develop a global strategy for infection control in hospitals. This paper provides an overview of the main IC practices employed during the 2003 SARS outbreak, including management measures, dedicated SARS hospitals, personal protective equipment, isolation, handwashing, environmental decontamination, education and training. The psychological and psychosocial impact on HCWs during the outbreak are also discussed. Requirements for IC programmes in the post-SARS period are proposed based on the major lessons learnt from the SARS outbreak.
DOI: 10.1016/j.puhe.2005.10.002
PubMed: 16297415
Links to Exploration step
pubmed:16297415Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The 2003 SARS outbreak and its impact on infection control practices.</title><author><name sortKey="Shaw, Karen" sort="Shaw, Karen" uniqKey="Shaw K" first="Karen" last="Shaw">Karen Shaw</name><affiliation><nlm:affiliation>Health Protection Agency, South East Regional Office, 6th Floor New Court, 48 Carey Street, London WC2A 2JE, UK. karen.shaw@hpa.org.uk</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2006">2006</date><idno type="RBID">pubmed:16297415</idno><idno type="pmid">16297415</idno><idno type="doi">10.1016/j.puhe.2005.10.002</idno><idno type="wicri:Area/PubMed/Corpus">002443</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002443</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">The 2003 SARS outbreak and its impact on infection control practices.</title><author><name sortKey="Shaw, Karen" sort="Shaw, Karen" uniqKey="Shaw K" first="Karen" last="Shaw">Karen Shaw</name><affiliation><nlm:affiliation>Health Protection Agency, South East Regional Office, 6th Floor New Court, 48 Carey Street, London WC2A 2JE, UK. karen.shaw@hpa.org.uk</nlm:affiliation></affiliation></author></analytic><series><title level="j">Public health</title><idno type="ISSN">0033-3506</idno><imprint><date when="2006" type="published">2006</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Coronavirus (pathogenicity)</term><term>Disease Outbreaks</term><term>Humans</term><term>Infection Control (methods)</term><term>Infectious Disease Transmission, Patient-to-Professional</term><term>Severe Acute Respiratory Syndrome (epidemiology)</term><term>Severe Acute Respiratory Syndrome (transmission)</term><term>State Medicine</term><term>United Kingdom (epidemiology)</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term><term>United Kingdom</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Infection Control</term></keywords><keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>Coronavirus</term></keywords><keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Disease Outbreaks</term><term>Humans</term><term>Infectious Disease Transmission, Patient-to-Professional</term><term>State Medicine</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Severe Acute Respiratory Syndrome (SARS) emerged recently as a new infectious disease that was transmitted efficiently in the healthcare setting and particularly affected healthcare workers (HCWs), patients and visitors. The efficiency of transmission within healthcare facilities was recognised following significant hospital outbreaks of SARS in Canada, China, Hong Kong, Singapore, Taiwan and Vietnam. The causative agent of SARS was identified as a novel coronavirus, the SARS coronavirus. This was largely spread by direct or indirect contact with large respiratory droplets, although airborne transmission has also been reported. High infection rates among HCWs led initially to the theory that SARS was highly contagious and the concept of 'super-spreading events'. Such events illustrated that lack of infection control (IC) measures or failure to comply with IC precautions could lead to large-scale hospital outbreaks. SARS was eventually contained by the stringent application of IC measures that limited exposure of HCWs to potentially infectious individuals. As the 'global village' becomes smaller and other microbial threats to health emerge, or re-emerge, there is an urgent need to develop a global strategy for infection control in hospitals. This paper provides an overview of the main IC practices employed during the 2003 SARS outbreak, including management measures, dedicated SARS hospitals, personal protective equipment, isolation, handwashing, environmental decontamination, education and training. The psychological and psychosocial impact on HCWs during the outbreak are also discussed. Requirements for IC programmes in the post-SARS period are proposed based on the major lessons learnt from the SARS outbreak.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">16297415</PMID><DateCompleted><Year>2006</Year><Month>01</Month><Day>26</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0033-3506</ISSN><JournalIssue CitedMedium="Print"><Volume>120</Volume><Issue>1</Issue><PubDate><Year>2006</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Public health</Title><ISOAbbreviation>Public Health</ISOAbbreviation></Journal><ArticleTitle>The 2003 SARS outbreak and its impact on infection control practices.</ArticleTitle><Pagination><MedlinePgn>8-14</MedlinePgn></Pagination><Abstract><AbstractText>Severe Acute Respiratory Syndrome (SARS) emerged recently as a new infectious disease that was transmitted efficiently in the healthcare setting and particularly affected healthcare workers (HCWs), patients and visitors. The efficiency of transmission within healthcare facilities was recognised following significant hospital outbreaks of SARS in Canada, China, Hong Kong, Singapore, Taiwan and Vietnam. The causative agent of SARS was identified as a novel coronavirus, the SARS coronavirus. This was largely spread by direct or indirect contact with large respiratory droplets, although airborne transmission has also been reported. High infection rates among HCWs led initially to the theory that SARS was highly contagious and the concept of 'super-spreading events'. Such events illustrated that lack of infection control (IC) measures or failure to comply with IC precautions could lead to large-scale hospital outbreaks. SARS was eventually contained by the stringent application of IC measures that limited exposure of HCWs to potentially infectious individuals. As the 'global village' becomes smaller and other microbial threats to health emerge, or re-emerge, there is an urgent need to develop a global strategy for infection control in hospitals. This paper provides an overview of the main IC practices employed during the 2003 SARS outbreak, including management measures, dedicated SARS hospitals, personal protective equipment, isolation, handwashing, environmental decontamination, education and training. The psychological and psychosocial impact on HCWs during the outbreak are also discussed. Requirements for IC programmes in the post-SARS period are proposed based on the major lessons learnt from the SARS outbreak.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shaw</LastName><ForeName>Karen</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Health Protection Agency, South East Regional Office, 6th Floor New Court, 48 Carey Street, London WC2A 2JE, UK. karen.shaw@hpa.org.uk</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2005</Year><Month>11</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Public Health</MedlineTA><NlmUniqueID>0376507</NlmUniqueID><ISSNLinking>0033-3506</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D017934" MajorTopicYN="N">Coronavirus</DescriptorName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017053" MajorTopicYN="N">Infection Control</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017758" MajorTopicYN="Y">Infectious Disease Transmission, Patient-to-Professional</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045169" MajorTopicYN="N">Severe Acute Respiratory Syndrome</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000635" MajorTopicYN="Y">transmission</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013222" MajorTopicYN="N">State Medicine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006113" MajorTopicYN="N">United Kingdom</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2005</Year><Month>11</Month><Day>22</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2006</Year><Month>1</Month><Day>27</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2005</Year><Month>11</Month><Day>22</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">16297415</ArticleId><ArticleId IdType="pii">S0033-3506(05)00236-2</ArticleId><ArticleId IdType="doi">10.1016/j.puhe.2005.10.002</ArticleId><ArticleId IdType="pmc">PMC7118748</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>CMAJ. 2003 May 13;168(10):1245-51</Citation><ArticleIdList><ArticleId IdType="pubmed">12743065</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Science. 2003 Jun 20;300(5627):1961-6</Citation><ArticleIdList><ArticleId IdType="pubmed">12766206</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Emerg Infect Dis. 2004 Feb;10(2):251-5</Citation><ArticleIdList><ArticleId IdType="pubmed">15030692</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Nurs Outlook. 2003 Sep-Oct;51(5):212-9</Citation><ArticleIdList><ArticleId IdType="pubmed">14569227</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Am J Infect Control. 2001 Oct;29(5):321-8</Citation><ArticleIdList><ArticleId IdType="pubmed">11584259</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>MMWR Morb Mortal Wkly Rep. 2003 May 23;52(20):461-6</Citation><ArticleIdList><ArticleId IdType="pubmed">12807078</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Med Microbiol. 2003 Aug;52(Pt 8):715-720</Citation><ArticleIdList><ArticleId IdType="pubmed">12867568</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Emerg Infect Dis. 2004 Feb;10(2):244-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15030690</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Infect Control Hosp Epidemiol. 1997 Oct;18(10):710-2</Citation><ArticleIdList><ArticleId IdType="pubmed">9350464</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Lancet. 2003 May 3;361(9368):1519-20</Citation><ArticleIdList><ArticleId IdType="pubmed">12737864</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Emerg Infect Dis. 2004 Mar;10(3):395-400</Citation><ArticleIdList><ArticleId IdType="pubmed">15109403</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1977-85</Citation><ArticleIdList><ArticleId IdType="pubmed">12671062</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>BMJ. 2004 Jan 24;328(7433):195</Citation><ArticleIdList><ArticleId IdType="pubmed">14726369</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Science. 2003 Jun 20;300(5627):1966-70</Citation><ArticleIdList><ArticleId IdType="pubmed">12766207</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>MMWR Recomm Rep. 2003 Jun 6;52(RR-10):1-42</Citation><ArticleIdList><ArticleId IdType="pubmed">12836624</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Am J Infect Control. 2004 Nov;32(7):377-83</Citation><ArticleIdList><ArticleId IdType="pubmed">15525911</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Respirology. 2003 Nov;8 Suppl:S41-5</Citation><ArticleIdList><ArticleId IdType="pubmed">15018133</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Emerg Infect Dis. 2003 Jun;9(6):718-20</Citation><ArticleIdList><ArticleId IdType="pubmed">12781013</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Am J Infect Control. 2005 Mar;33(2):114-21</Citation><ArticleIdList><ArticleId IdType="pubmed">15761412</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Emerg Med J. 2004 May;21(3):311-6</Citation><ArticleIdList><ArticleId IdType="pubmed">15107369</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Emerg Infect Dis. 2004 Jul;10(7):1187-94</Citation><ArticleIdList><ArticleId IdType="pubmed">15324536</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Philos Trans R Soc Lond B Biol Sci. 2004 Jul 29;359(1447):1117-25</Citation><ArticleIdList><ArticleId IdType="pubmed">15306398</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Emerg Infect Dis. 2004 Feb;10(2):256-60</Citation><ArticleIdList><ArticleId IdType="pubmed">15030693</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1967-76</Citation><ArticleIdList><ArticleId IdType="pubmed">12690091</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>N Engl J Med. 2004 Apr 22;350(17):1731-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15102999</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Emerg Med J. 2003 Nov;20(6):501-4</Citation><ArticleIdList><ArticleId IdType="pubmed">14623831</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Emerg Infect Dis. 2004 Feb;10(2):265-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15030695</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Lancet Infect Dis. 2004 Nov;4(11):690-6</Citation><ArticleIdList><ArticleId IdType="pubmed">15522681</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Lancet. 2003 Apr 19;361(9366):1386</Citation><ArticleIdList><ArticleId IdType="pubmed">12711488</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Am J Infect Control. 2000 Jun;28(3):211-21</Citation><ArticleIdList><ArticleId IdType="pubmed">10840340</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Lancet Infect Dis. 2005 Apr;5(4):242-50</Citation><ArticleIdList><ArticleId IdType="pubmed">15792742</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Lancet. 1994 Nov 12;344(8933):1311-2</Citation><ArticleIdList><ArticleId IdType="pubmed">7968023</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Emerg Infect Dis. 2004 Feb;10(2):280-6</Citation><ArticleIdList><ArticleId IdType="pubmed">15030698</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Emerg Infect Dis. 2004 May;10(5):771-6</Citation><ArticleIdList><ArticleId IdType="pubmed">15200807</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Lancet. 2000 Oct 14;356(9238):1307-12</Citation><ArticleIdList><ArticleId IdType="pubmed">11073019</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Emerg Infect Dis. 2004 May;10(5):777-81</Citation><ArticleIdList><ArticleId IdType="pubmed">15200808</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Emerg Infect Dis. 2004 Feb;10(2):269-76</Citation><ArticleIdList><ArticleId IdType="pubmed">15030696</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>N Engl J Med. 2004 Jun 3;350(23):2352-61</Citation><ArticleIdList><ArticleId IdType="pubmed">15175437</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>CMAJ. 2003 Aug 19;169(4):285-92</Citation><ArticleIdList><ArticleId IdType="pubmed">12925421</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Curr Infect Dis Rep. 2003 Dec;5(6):473-476</Citation><ArticleIdList><ArticleId IdType="pubmed">14642187</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Ann Intern Med. 2003 Oct 7;139(7):564-7</Citation><ArticleIdList><ArticleId IdType="pubmed">14530227</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>CMAJ. 2004 Mar 2;170(5):793-8</Citation><ArticleIdList><ArticleId IdType="pubmed">14993174</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Can Commun Dis Rep. 2003 Jun 1;29(11):93-7</Citation><ArticleIdList><ArticleId IdType="pubmed">12794968</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Hosp Infect. 2004 Mar;56(3):249-50</Citation><ArticleIdList><ArticleId IdType="pubmed">15003680</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>BMJ. 2004 Jul 10;329(7457):83</Citation><ArticleIdList><ArticleId IdType="pubmed">15175231</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Lancet. 2003 Apr 19;361(9366):1319-25</Citation><ArticleIdList><ArticleId IdType="pubmed">12711465</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Ann Intern Med. 1999 Jan 19;130(2):126-30</Citation><ArticleIdList><ArticleId IdType="pubmed">10068358</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>MMWR Morb Mortal Wkly Rep. 2003 May 9;52(18):405-11</Citation><ArticleIdList><ArticleId IdType="pubmed">12807088</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002443 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 002443 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:16297415
|texte= The 2003 SARS outbreak and its impact on infection control practices.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:16297415" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |